News

23
Aug

ESDR2019

Genoskin to exhibit at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR 2019) The 44th Annual Meeting of the European Society for Dermatological Research (ESDR 2019) strives to provide a world-leading platform for the presentation and discussion of state-of-the-art science as it relates to skin biology and investigative dermatology. From September 18th to September 21st, meet our Chief Commercial Officer, Eric
Read more
20
Aug

Illinois bans cosmetic tests on animals

Illinois becomes the third state to ban cosmetics tests on animals Last week, Illinois became the third state to ban the sale and manufacture of cosmetic products tested on animals. About a year ago, California was the first state to take a stand against animal testing in cosmetics, Nevada followed a few months later. The law, sponsored by Sen. Linda
Read more
14
Aug

InflammaSkin® application presented by Incospharm at GRC

InflammaSkin® application presented by Incospharm at the Gordon Research Conference (GRC) on Barrier Function of Mammalian Skin Incospharm is presenting a poster showing one application of our live human psoriasis model, InflammaSkin® at the GRC held in New Hampshire from August 11th to August 16th. InflammaSkin®, testing of innovative anti-inflammatory drugs Poster title: "ICP-5249 reduces dermal inflammatory signaling through autophagy activation" Incospharm
Read more
27
May

Genoskin to attend BIO 2019 in Philadelphia, PA

Genoskin will attend the BIO International Convention in Philadelphia, PA The BIO International Convention is a global event regrouping biotech and pharma leaders over intensive networking. The convention is a great opportunity to discuss a wide spectrum of life science and application areas including drug discovery, bio manufacturing, genomics, biofuels, nanotechnology or cell therapy. This year more than 16,000 attendees
Read more
17
May

Genoskin recrute un Responsable R&D et Innovation

Genoskin recruiting for Skin Immunotoxicology R&D and Innovation Manager Who we are: Genoskin (genoskin.com) is a biotechnology company that was created in 2011. The company is based in Toulouse (France) and also has an office in Salem, MA (Boston area, USA). Genoskin is a leader and pioneer in standardized human skin biopsies for ex vivo clinical testing. Thanks to a patented

Read more

8
May

SID2019: Preserving skin integrity and metabolism

SID2019: Genoskin validates skin integrity and metabolism at 10 days with Promega Glucose-Glo™ and Lac­tate-Glo™ Assays Genoskin’s team of skin experts will be presenting its latest work at the 77th SID Annual Meeting from May 8 to May 11 in Chicago. To learn more about our live human skin models and R&D services, swing by booth #106. Our Chief Commercial
Read more